Radiomic signatures of brain metastases on MRI: utility in predicting pathological subtypes of lung cancer

被引:0
|
作者
Sun, Linlin [1 ]
Luan, Shihai [2 ,3 ,4 ]
Yu, Liheng [5 ]
Zhu, Huiyuan [1 ]
Dong, Haiyang [1 ]
Liu, Xuemei [1 ]
Tao, Guangyu [1 ]
He, Pengbo [6 ,7 ,8 ]
Li, Qiang [6 ,7 ,8 ]
Chen, Weiqiang [6 ,7 ,8 ,9 ]
Yu, Zekuan [5 ]
Yu, Hong [1 ]
Zhu, Li [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Sch Med, Dept Radiol, 241 Huaihai West Rd, Shanghai 200030, Peoples R China
[2] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China
[3] Fudan Univ, Inst Neurosurg, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Key Lab Brain Funct Restorat & Neural Reg, Shanghai, Peoples R China
[5] Fudan Univ, Acad Engn & Technol, Shanghai, Peoples R China
[6] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China
[7] Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Gansu, Peoples R China
[8] Key Lab Basic Res Heavy Ion Radiat Applicat Med, Lanzhou, Gansu, Peoples R China
[9] Univ Chinese Acad Sci, Inst Modern Phys, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Radiomics; brain metastases (BM); lung cancer; magnetic resonance imaging (MRI); machine learning (ML); TEXTURE ANALYSIS; HIGH-RESOLUTION; HIGH-FIELD; CONTRAST; EPIDEMIOLOGY; IMAGES;
D O I
10.21037/tcr-24-1147
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The pathological sub-classification of lung cancer is crucial in diagnosis, treatment and prognosis for patients. Quick and timely identification of pathological subtypes from imaging examinations rather than histological tests could help guiding therapeutic strategies. The aim of the study is to construct a non-invasive radiomics-based model for predicting the subtypes of lung cancer on brain metastases (BMs) from multiple magnetic resonance imaging (MRI) sequences. Methods: One hundred and sixty-one patients of primary lung cancer with synchronous BMs [121 with adenocarcinoma (AD); 40 with small cell lung carcinoma (SCLC)] were enrolled in the study (129 and 32 in the training set and validation set). A total of 960 radiomics features were extracted from multiple MRI sequences [fluid attenuated inversion recovery (FLAIR), diffusion weighted imaging (DWI), contrast- enhanced T1 weighted imaging (CE-T1WI) and contrast-enhanced susceptibility weighted imaging (CESWI)] and four clinical features were recorded. Forty-one key features were selected by the least absolute shrinkage selection operator (LASSO). The machine learning (ML) models for predicting AD and SCLC with radiomics features alone and with radiomics features plus clinical features were constructed using classifiers of logistic regression (LR), random forest (RF), support vector machine (SVM) and extreme gradient boosting (XGBoost). The prediction performance of models was evaluated by accuracy (ACC), sensitivity (SEN), specificity (SPE), F1 score and area under the curves (AUC). Results: The AUCs of LR, RF, SVM and XGBoost models were 0.8177 vs. 0.7604, 0.8177 vs. 0.7839, 0.4792 vs. 0.8594 and 0.9062 vs. 0.8750, respectively, when using radiomics features alone and radiomics features plus clinical features. In the best-performing model using XGBoost, combination of conventional MRI sequences and CE-SWI had better sub-classification performance than conventional MRI sequences. Conclusions: Radiomics of BMs from multiple MRI sequences provides high discriminatory performance in predicting AD and SCLC using classifiers of LR, RF and XGBoost, and can serve as a potential useful tool to non-invasively distinguish pathological subtypes of lung cancer.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Breast cancer subtypes and survival in patients with brain metastases
    Nam, Byung-Ho
    Kim, Sun Young
    Han, Hye-Sook
    Kwon, Youngmee
    Lee, Keun Seok
    Kim, Tae Hyun
    Ro, Jungsil
    BREAST CANCER RESEARCH, 2008, 10 (01):
  • [32] Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer
    Chintan Parmar
    Ralph T. H. Leijenaar
    Patrick Grossmann
    Emmanuel Rios Velazquez
    Johan Bussink
    Derek Rietveld
    Michelle M. Rietbergen
    Benjamin Haibe-Kains
    Philippe Lambin
    Hugo J.W.L. Aerts
    Scientific Reports, 5
  • [33] Brain metastases in lung cancer.
    Koko, I
    Mullai, N
    Samuel, J
    Hussein, LP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 692S - 692S
  • [34] Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer
    Parmar, Chintan
    Leijenaar, Ralph T. H.
    Grossmann, Patrick
    Velazquez, Emmanuel Rios
    Bussink, Johan
    Rietveld, Derek
    Rietbergen, Michelle M.
    Haibe-Kains, Benjamin
    Lambin, Philippe
    Aerts, Hugo J. W. L.
    SCIENTIFIC REPORTS, 2015, 5
  • [35] The treatment of brain metastases in lung cancer
    Monnet, I.
    Rousseau-Bussac, G.
    Jabot, L.
    Chouaid, C.
    ONCOLOGIE, 2016, 18 (06) : 376 - 384
  • [36] Miliary Brain Metastases in Lung Cancer
    Ruppert, Anne-Marie
    Stankoff, Bruno
    Lavole, Armelle
    Gounant, Valerie
    Milleron, Bernard
    Seilhean, Danielle
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) : E714 - E716
  • [37] FACTORS PREDICTING BRAIN METASTASES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hsiao, S.
    Chung, C.
    Liu, H. E.
    ANNALS OF ONCOLOGY, 2012, 23 : 428 - 429
  • [38] MRI in detection of brain metastases at initial staging of small-cell lung cancer
    vandePol, M
    vanOosterhout, AGM
    Wilmink, JT
    tenVelde, GPM
    Twijnstra, A
    NEURORADIOLOGY, 1996, 38 (03) : 207 - 210
  • [39] Longitudinal MRI evaluation of the efficacy of non-enhanced lung cancer brain metastases
    Zhang, Xian
    Yang, Jun
    Hu, Hong
    Wang, Yong
    Zhang, Zhenfeng
    Lv, Jinhao
    Li, Junping
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [40] Pathological and Molecular Characteristics of Colorectal Cancer with Brain Metastases
    Roussille, Pauline
    Tachon, Gaelle
    Villalva, Claire
    Milin, Serge
    Frouin, Eric
    Godet, Julie
    Berger, Antoine
    Emambux, Sheik
    Petropoulos, Christos
    Wager, Michel
    Karayan-Tapon, Lucie
    Tougeron, David
    CANCERS, 2018, 10 (12)